20250179502. Targeting Neuropil (UNIVERSITY OF MASSACHUSETTS)
TARGETING NEUROPILIN 2 (NRP2) IN LETHAL PROSTATE CANCER
Abstract: described herein are compositions and methods for use in targeting neuropilin 2 (nrp2) in lethal prostate cancer, e.g., in metastatic castration-resistant prostate cancer (mcrpc) or neuroendocrine prostate cancer (nepc).
Inventor(s): Arthur M. MERCURIO, Mengdie WANG
CPC Classification: C12N15/1138 ({against receptors or cell surface proteins})
Search for rejections for patent application number 20250179502